Kosé is partnering with I Peace, Inc. and Reju, Inc. to develop personalized beauty products comprising iPSF (an induced pluripotent stem [iPS] cell extract) derived from customers’ own blood-drawn cells.
This process will reportedly optimize dosages and textures for each consumer; finished products will reportedly be “provided through medical institutions under medical supervision,” per Kosé.
By the end of 2024, iPSF-based formulations will commence demonstrating testing in Japan.
GBA Group is a leading group of laboratories with a solid reputation backed by over…
Now, INTECH CO. developed stripping tape to collect Dead skin cell. - Basic Skin Research…
K-Beauty's Global Takeover: A Success Story The Korean beauty industry has achieved an unprecedented milestone:…